Eric Paul, a Senior Officer and Director, disposed of 434,500 Common Shares on an indirect ownership basis for registered holder The Paul Family Trust at prices ranging from $8.400 to $9.411 between December 28th and 2nd, 2018. This represents a $3,795,475 divestment of the company's shares and an account share holdings change of -3.5%.
Mark Litwin, a Senior Officer and Director, disposed of 50,000 Common Shares on an indirect ownership basis for registered holder Mar-Risa Holdings Inc. at a price of $9.783 on January 2nd, 2018. This represents a $489,150 divestment of the company's shares and an account share holdings change of -1.7%.
Ian Abramowitz, a Senior Officer, disposed of 25,000 Common Shares on a direct ownership basis at prices ranging from $9.314 to $11.000 between January 2nd and 3rd, 2018. This represents a $246,697 divestment of the company's shares and an account share holdings change of -33.3%.
CannTrust Holdings is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
CannTrust Holdings Inc is a Canada-based company, which produces pharmaceutical-grade medical cannabis for patients. The Company is a federally regulated licensed producer of medical cannabis products. The Company operates a hydroponic facility and an onsite laboratory for testing and research on the medical use of cannabis. The Company's exclusive pharmaceutical partner is Apotex. CannTrust Holdings Inc's products are divided into the following: Products Type, such as oil, dried cannabis, accessories and patient ready; Strain Type, such as hybrid, sativa dominant and indica dominant, as well as Strength, such as strong, mild and moderate. The Company's products are sold online through its Website.
No Comments